Table 4 Comparison of estimates measuring the relation between malaria transmission and mortality from previous studies and current work

(All-cause)

Log EIR^a

3.91 (3.53–4.32)

3.64 (3.40–3.89)

4.29 (3.89–4.73)

–

–

–

–

Slide Positivity Rate (Incidence)^b

0.89 (0.13–5.70)

3.10 (0.36–13.12)

4.29 (2.78–13.29)

0.48 (0.15–2.05)

0.73 (0.39–1.42)

1.70 (0.79–4.45)

1.55 (1.04–2.80)

Annual parasite prevalence^c

1.23 (0.71–2.10)

1.04 (0.75–1.42)

1.11 (0.80–1.52)

1.15 (0.67–1.98)

1.23 (1.01–1.50)

1.04 (0.86–1.28)

1.10 (0.97–1.25)

Annual clinical malaria prevalence^c

1.03 (0.44–2.32)

1.22 (0.68–1.84)

1.38 (0.87–2.19)

1.97 (0.88–4.17)

1.16 (0.86–1.58)

0.99 (0.72–1.36)

1.16 (0.97–1.40)

Five-year parasite prevalence^d

0.64 (0.29–1.34)

1.32 (0.86–2.04)

1.50 (0.98–2.23)

1.38 (0.69–2.69)

1.23 (0.94–1.57)

1.04 (0.78–1.35)

1.15 (0.96–1.37)

Five-year clinical malaria prevalence^d

1.05 (0.30–3.51)

1.65 (0.81–3.26)

1.89 (1.00–3.51)

3.94 (1.34–11.1)

0.99 (0.64–1.54)

1.07 (0.69–1.66)

1.32 (1.01–1.74)

(Malaria-specific)

Log EIR^a

–

4.35 (3.72–4.95)

4.29 (3.61–5.06)

–

–

–

–

Slide Positivity Rate (Incidence)^b

–

1.36 (0.23–9.85)

9.48 (5.11–37.94)

0.02 (0.003–0.33)

0.27 (0.02–3.24)

0.59 (0.01–13.15)

1.37 (0.51–3.73)

Annual parasite prevalence^c

–

1.31 (0.71–2.37)

1.50 (0.92–2.41)

0.80 (0.32–2.06)

0.78 (0.32–1.80)

3.42 (1.39–8.63)

1.31 (0.95–1.78)

Annual clinical malaria prevalence^c

–

0.94 (0.34–2.47)

1.58 (0.73–3.23)

3.65 (0.94–12.79)

0.36 (0.08–1.49)

1.67 (0.38–6.52)

1.34 (0.82–2.14)

Five-year parasite prevalence^d

–

1.73 (0.74–4.21)

2.29 (1.17–4.29)

0.56 (0.14–2.03)

1.55 (0.48–4.86)

2.24 (0.67–7.44)

1.66 (1.07–2.54)

Five-year clinical malaria prevalence^d

–

2.23 (0.55–8.36)

3.37 (1.23–8.93)

7.56 (1.20–39.5)

0.60 (0.08–3.91)

0.77 (0.09–5.64)

2.50 (1.27–4.81)